Could a Blood Test Reveal Hidden MS Brain Activity?

Could a Blood Test Reveal Hidden MS Brain Activity?
Credibility
Interest
Share:2 min read
Key Takeaway

A blood substance called CHIT1 was linked to ongoing activity around some MS brain spots, but the test is not ready to guide care.

What They Found

Researchers studied blood samples and brain scans from 89 people with MS and 16 people without MS. They focused on brain spots with active edges, where certain support cells remain active around older areas of damage. Among people with higher CHIT1 levels, more CHIT1 in the blood was linked to more of these active-edge spots. CHIT1 was also linked to two other blood signs of stress or damage in the nervous system. In donated MS brain tissue, researchers found more CHIT1 in active spots and along the edges of older, still-active spots than in nearby tissue.

Who Should Care and Why

People with MS may find this useful because activity in the brain is not always easy to notice in daily life. A blood test that helps track such activity could someday add another piece to the picture, like an extra gauge on a dashboard. Caregivers may also benefit from understanding why care teams look beyond symptoms when checking MS. For now, ask your MS care team what your current scans and tests show rather than seeking a CHIT1 test on your own. Researchers and healthcare providers can use these findings to study whether CHIT1 could help monitor MS in the future.

Important Considerations

The blood-test link to active-edge spots was found in an exploratory subgroup of people with higher CHIT1, so it may not apply to everyone with MS. The study captured one point in time, so it cannot show whether CHIT1 predicts future symptoms or worsening MS. More research is needed before this test can be used to make treatment decisions.

AI-generated summary — for informational purposes only, not medical advice

You May Also Like

Childhood MS blood patterns linked to Epstein-Barr virus
Childhood MS blood patterns linked to Epstein-Barr virus

11/1/2026

Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN

Read More
Stem Cell Treatment May Calm MS Brain Inflammation
Stem Cell Treatment May Calm MS Brain Inflammation

11/1/2026

In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for

Read More
New Brain Scans May Reveal Hidden Inflammation in MS
New Brain Scans May Reveal Hidden Inflammation in MS

11/1/2026

A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method

Read More
MS Study Finds Hidden Immune Cells That Treatment Targets
MS Study Finds Hidden Immune Cells That Treatment Targets

10/6/2026

Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu

Read More
What Immune Clues May Reveal About MS Risk in Children
What Immune Clues May Reveal About MS Risk in Children

10/6/2026

In children with MS, immune attacks on the brain and spinal cord may go unchecked. See what research

Read More
What Brain Protein Research Could Mean for People With MS
What Brain Protein Research Could Mean for People With MS

10/6/2026

A review finds a changed protein in several brain diseases, but its role in MS is unclear. Learn wha

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Annals of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.